Objectives: To evaluate the effect of minocycline as treatment for cutaneous calcinosis in limited cutaneous systemic sclerosis (lcSSc). Methods: Patients with lcSSc who had cutaneous calcinosis ...

Systemic sclerosis. Digital ulcers Rapidly progressing skin involvement, digital pitting scars, calcinosis high levels of IL-6, LAC and avascular areas at NVC Gangrene, osteomyelitis, septicemia ...

Objective To examine the outcomes of hand radiographic x-rays in patients with systemic sclerosis (SSc) and to identify risk ... acro-osteolysis, calcinosis and flexion contracture occurred in 24, 22, ...

Frailty among patients with systemic sclerosis significantly increases the risk for mortality by nearly 10-fold, but shows ...

Sex-related differences in pulmonary complications were found among men vs women with SSc, specifically in the prevalence of ILD and SAD.

in patients with systemic sclerosis–associated interstitial lung disease (SSc-ILD) in the following year. Despite available treatments, about 25% of patients with SSc-ILD develop PPF ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

Counteracting misinformation requires systemic efforts, Lazer says, including tools to help people recognize false information. He highlights the challenge of addressing misinformation in complex ...

When it comes to the outlook for multiple sclerosis (MS), there’s both good news and bad news. Although MS isn’t fatal, there’s currently no cure — MS is a chronic condition. But many ...

Rapcabtagene autoleucel is under clinical development by Novartis and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis ...